Ligand Pharmaceuticals LGND Gain (Loss) on Disposition of Other Assets
Gain (Loss) on Disposition of Other Assets at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnSaleOfOtherAssets.
The official record: Ligand Pharmaceuticals’s 10-K, filed February 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's gain (loss) on disposition of other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's gain (loss) on disposition of other assets?
- Ligand Pharmaceuticals (LGND) reported gain (loss) on disposition of other assets of $13.27M in Q4 2025.